Literature DB >> 10323586

Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.

M Connor1, A Schuller, J E Pintar, M J Christie.   

Abstract

1. The actions of opioid receptor agonists on the calcium channel currents (IBa) of acutely dissociated periaqueductal grey (PAG) neurons from C57B16/J mice and mutant mice lacking the first exon of the mu-opioid receptor (MOR-1) were examined using whole cell patch clamp techniques. These effects were compared with the GABA(B)-receptor agonist baclofen. 2. The endogenous opioid agonist methionine-enkephalin (met-enkephalin, pEC50 6.8, maximum inhibition 40%), the putative endogenous mu-opioid agonist endomorphin-1 (pEC50 6.2, maximum inhibition 35%) and the mu-opioid selective agonist DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin, pEC50 6.9, maximum inhibition 40%) inhibited IBa in 70% of mouse PAG neurons. The inhibition of IBa by each agonist was completely prevented by the mu-receptor antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2). The delta-opioid receptor agonists DPDPE ([D-Pen2,5]enkephalin, 1 microM) and deltorphin II (1 microM), and the kappa-opioid receptor agonist U-69593 (1-10 microM), did not affect IBa in any cell tested. 3. The GABA(B) agonist baclofen inhibited IBa in all neurons (pEC50 5.9, maximum inhibition 42%). 4. In neurons from the MOR-1 deficient mice, the mu-opioid agonists met-enkephalin, DAMGO and endomorphin-1 did not inhibit IBa, whilst baclofen inhibited IBa in a manner indistinguishable from wild type mice. 5. A maximally effective concentration of endomorphin-1 (30 microM) partially (19%), but significantly (P<0.005), occluded the inhibition of IBa normally elicited by a maximally effective concentration of met-enkephalin (10 microM). 6. This study indicates that mu-opioid receptors, but not delta- or kappa-opioid receptors, modulate somatic calcium channel currents in mouse PAG neurons. The putative endogenous mu-agonist, endomorphin-1, was a partial agonist in mouse PAG neurons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323586      PMCID: PMC1565931          DOI: 10.1038/sj.bjp.0702457

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes.

Authors:  L M Harrison; A J Kastin; J E Zadina
Journal:  Peptides       Date:  1998       Impact factor: 3.750

2.  Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors.

Authors:  L J Sim; Q Liu; S R Childers; D E Selley
Journal:  J Neurochem       Date:  1998-04       Impact factor: 5.372

3.  Ca2+ channel inhibition by endomorphins via the cloned mu-opioid receptor expressed in NG108-15 cells.

Authors:  H Mima; H Morikawa; K Fukuda; S Kato; T Shoda; K Mori
Journal:  Eur J Pharmacol       Date:  1997-12-11       Impact factor: 4.432

4.  Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene.

Authors:  I Kitchen; S J Slowe; H W Matthes; B Kieffer
Journal:  Brain Res       Date:  1997-12-05       Impact factor: 3.252

5.  Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.

Authors:  A G Schuller; M A King; J Zhang; E Bolan; Y X Pan; D J Morgan; A Chang; M E Czick; E M Unterwald; G W Pasternak; J E Pintar
Journal:  Nat Neurosci       Date:  1999-02       Impact factor: 24.884

6.  Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons.

Authors:  M Connor; M J Christie
Journal:  J Physiol       Date:  1998-05-15       Impact factor: 5.182

7.  Characterization of endomorphin-1 and -2 on [35S]GTPgammaS binding in the mouse spinal cord.

Authors:  M Narita; H Mizoguchi; G S Oji; E L Tseng; C Suganuma; H Nagase; L F Tseng
Journal:  Eur J Pharmacol       Date:  1998-06-26       Impact factor: 4.432

8.  Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor.

Authors:  K Hosohata; T H Burkey; J Alfaro-Lopez; E Varga; V J Hruby; W R Roeske; H I Yamamura
Journal:  Eur J Pharmacol       Date:  1998-04-03       Impact factor: 4.432

9.  Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain.

Authors:  I E Goldberg; G C Rossi; S R Letchworth; J P Mathis; J Ryan-Moro; L Leventhal; W Su; D Emmel; E A Bolan; G W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

10.  Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.

Authors:  A Alt; A Mansour; H Akil; F Medzihradsky; J R Traynor; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more
  15 in total

1.  Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance.

Authors:  Adrianne R Wilson-Poe; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  J Physiol       Date:  2017-09-07       Impact factor: 5.182

2.  Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice.

Authors:  Emma E Johnson; Billy Chieng; Ian Napier; Mark Connor
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

3.  Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.

Authors:  Leon W Fyfe; Daniel R Cleary; Tara A Macey; Michael M Morgan; Susan L Ingram
Journal:  J Pharmacol Exp Ther       Date:  2010-08-25       Impact factor: 4.030

4.  Endomorphin-2: a biased agonist at the μ-opioid receptor.

Authors:  Guadalupe Rivero; Javier Llorente; Jamie McPherson; Alex Cooke; Stuart J Mundell; Craig A McArdle; Elizabeth M Rosethorne; Steven J Charlton; Cornelius Krasel; Christopher P Bailey; Graeme Henderson; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2012-05-02       Impact factor: 4.436

5.  Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.

Authors:  Stephen P Hack; Elena E Bagley; Billy C H Chieng; MacDonald J Christie
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

6.  Opioids differentially modulate two synapses important for pain processing in the amygdala.

Authors:  Sarah A Kissiwaa; Sahil D Patel; Bryony L Winters; Elena E Bagley
Journal:  Br J Pharmacol       Date:  2020-01-08       Impact factor: 8.739

7.  Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.

Authors:  Elena E Bagley; Billy C H Chieng; MacDonald J Christie; Mark Connor
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

8.  Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.

Authors:  Christopher W Vaughan; Elena E Bagley; Geoffrey M Drew; Alwin Schuller; John E Pintar; Stephen P Hack; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.

Authors:  M Connor; E E Bagley; B C Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

10.  Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.

Authors:  Jennifer T Lamberts; Chelsea E Smith; Ming-Hua Li; Susan L Ingram; Richard R Neubig; John R Traynor
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.